Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 91

1.

Ripazepam (CI-683): double-blind comparison with placebo in anxious patients.

Schneyer JJ, Goodman LI, Borgen LA.

J Clin Pharmacol. 1976 Jul;16(7):377-83.

PMID:
780378
2.

SQ 65,396: a non-sedative anxiolytic?

Sakalis G, Sathananthan G, Collins P, Gershon S.

Curr Ther Res Clin Exp. 1974 Aug;16(8):861-3. No abstract available.

PMID:
4375017
3.

A double-blind evaluation of fenfluramine in anxious somatizing neurotic medical clinic patients.

Raich WA, Rickels K, Raab E.

Curr Ther Res Clin Exp. 1966 Jan;8(1):31-3. No abstract available.

PMID:
4955145
4.

A controlled trial of benzoctamine (Ba-30803) in neurotic anxiety.

Kellner R, Claghorn JL.

J Clin Pharmacol J New Drugs. 1970 Sep-Oct;10(5):342-8. No abstract available.

PMID:
4917355
5.

Methodological considerations in evaluating antianxiety drugs.

Hollister LE.

J Clin Pharmacol J New Drugs. 1970 Jan-Feb;10(1):12-8. No abstract available.

PMID:
4903952
6.

Double-blind evaluation of prazepam, chlordiazepoxide and placebo in non-psychotic patients with anxiety and tension: some methodological considerations.

Kingstone E, Villeneuve A, Kossatz I.

Curr Ther Res Clin Exp. 1969 Mar;11(3):106-14. No abstract available.

PMID:
4976238
7.

Symptomatic relief with flupentixol (Fluanxol) of the anxious-algetic-depressive syndrome complex in neurotic states. A double-blind, placebo-controlled study.

Predescu V, Ciurezu T, Timofte G, Roman I.

Acta Psychiatr Scand. 1973;49(1):15-27. No abstract available.

PMID:
4572167
8.

Comparison of prazepam and placebo in the treatment of convalescing narcotic addicts.

Sugerman AA, Miksztal MW, Freymuth HW.

J Clin Pharmacol New Drugs. 1971 Sep-Oct;11(5):383-7. No abstract available.

PMID:
4935717
9.

SCH 12041. A new antianxiety agent.

Gallant DM, Bishop MP.

Curr Ther Res Clin Exp. 1971 Feb;13(2):107-10. No abstract available.

PMID:
4994212
10.

Placebo-controlled evaluation of phenaglycodol in anxious, depressed outpatients.

Brauzer B, Goldstein BJ.

J Clin Pharmacol New Drugs. 1972 Jul;12(7):280-5. No abstract available.

PMID:
4557536
11.
12.

A comparison between diazepam, dixyrazine, opripramol and placebo in anxiety states.

Arfwidsson L, Arn L, Beskow J, Ottosson JO, Persson G.

Acta Psychiatr Scand Suppl. 1971:19-32. No abstract available.

PMID:
4938880
13.

Controlled clinical trial of mepiprazole in irritable bowel syndrome.

Dotevall G, Groll E.

Br Med J. 1974 Oct 5;4(5935):16-8.

14.

[Clozapine in long-term therapy of chronic schizophrenia].

Gross H, Langner E, Pfolz H.

Arzneimittelforschung. 1974 Jul;24(7):987-9. German. No abstract available.

PMID:
4408041
15.
16.

Comparative study of TPS-23, chlorpromazine and placebo in chronic schizophrenic patients.

Tetreault L, Bordeleau JM, Gauthier R, Vulpe M, Lapointe L.

Dis Nerv Syst. 1969 Feb;30(2):Suppl:74-84. No abstract available.

PMID:
4886994
17.

Clinical evaluation of a new antianxiety agent Ba-30803.

Goldstein BJ, Weiner D.

J Clin Pharmacol J New Drugs. 1970 Jan-Feb;10(1):19-23. No abstract available.

PMID:
4905244
18.

[Comparative double blind study of doxepine and medazepam in adolescents].

Moniot M, Misés R.

Ann Med Psychol (Paris). 1971 Mar;1(3):431-4. French. No abstract available.

PMID:
4934283
19.

Maintenance therapy of chronic psychostic patients with a weekly oral dose of R 16 341. A controlled double-blind study.

Baro F, Brugmans J, Dom R, Van Lommel R.

J Clin Pharmacol J New Drugs. 1970 Sep-Oct;10(5):330-41. No abstract available.

PMID:
4917354
20.

Early phase-II semi double-blind study of the new alkaline propanolamine derivative enciprazine (short communication).

Linden M, Helmchen H, Müller-Oerlinghausen B.

Arzneimittelforschung. 1988 Jun;38(6):814-6.

PMID:
3178922

Supplemental Content

Support Center